OCTOBER 2023LIFE SCIENCES REVIEW5COMPANIES - 2023TOP 10CELL ANDGENE THERAPYPuresyn, Inc.32TargaZyme36Endsulin26Miltenyi Biomedicine GmbH28CXO INSIGHTS20Hong Ma, MD, Sr Vice President of Clinical Development, CARsgen TherapeuticsNovel Nanotechnology in CAR-T Therapy Targeting Solid Tumors27Alexis Bossie, Director, Media R&D, LonzaPotential of Cell and Gene Therapy24Matthew Hewitt, Vice President, Technical Officer CGT & Biologics, Charles RiverThe Evolving Cell and Gene Therapy Space34Dr. Linda Randall, AVP, Biologics Development, Manufacturing & Control, PharmaronThe Tipping Point for Scalable Manufacturing Processes to Pivot Gene Therapies29Anders Damholt, Head of Clinical Development, Human Health Innovation, Chr. HansenNew innovative Probiotics Programming the Infant MicrobiomeThomas Dee, Chairperson & CEOLinda Hanssens, Head of Clinical Research and Development and Medical AffairsLynnet Koh, Founder and CEOEDITOR'S CHOICEBrian Lee, Founder and CEOPBS Biotech22Dana Rosencrance,VP of Quality and Operations ManagerDenise Ortlip,Director of ProductionLeslie F. Orischak,VP and General ManagerMichael Moxley, Director of Business and Process Development
< Page 4 | Page 6 >